Corrixr Therapeutics

Developer of gene-based therapies for cancer treatment

placeNewark, Delaware, United States calendar_todayFounded 2022 groups6 employees language corrixr.com

Social engagement

Social engagement: 1.2K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Cortado Ventures.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

3 Jun 2026
Leadership hire
Chief Executive Officer
2 Jun 2026
Recognition
6 May 2026
Event
ASGT2026
Coming soon